Skip to main content
Year archive

CSPC Pharmaceutical Group Limited — 2018 filings

All 69 regulatory filings released by CSPC Pharmaceutical Group Limited (1093) in 2018, sourced directly from the official regulator.

69 Filings
2018 Period
2018 filings (69)
Filing Released Lang
CONTINUING CONNECTED TRANSACTIONS - LEASE AGREEMENTS
Regulatory Filings
2018-12-21 English
NEXT DAY DISCLOSURE RETURN - CHANGES IN ISSUED SHARE CAPITAL
Regulatory Filings
2018-12-18 English
VOLUNTARY ANNOUNCEMENT - PRODUCT LICENSING AND COMMERCIALIZATION AGREEMENT
Regulatory Filings
2018-12-17 English
PROGRESS UPDATE ON THE PROPOSED SPIN-OFF AND SEPARATE LISTING OF CSPC XNW GROUP ON THE SHENZHEN STOCK EXCHANGE
Regulatory Filings
2018-12-11 English
NEXT DAY DISCLOSURE RETURN
Regulatory Filings
2018-12-06 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 November 2018
Regulatory Filings
2018-12-03 English
VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR THE GROUP'S "AMOXICILLIN CAPSULES"
Regulatory Filings
2018-11-26 English
VOLUNTARY ANNOUNCEMENT - THE GROUP'S "TIROFIBAN HYDROCHLORIDE AND SODIUM CHLORIDE INJECTION" WAS GRANTED DRUG REGISTRATION APPROVAL
Regulatory Filings
2018-11-26 English
VOLUNTARY ANNOUNCEMENT - THE GROUP'S PRODUCT CANDIDATE "ALMB-0166" WAS GRANTED ORPHAN-DRUG DESIGNATION BY THE U.S. FDA
Regulatory Filings
2018-11-26 English
UNAUDITED RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2018
Regulatory Filings
2018-11-19 English
DATE OF BOARD MEETING
Regulatory Filings
2018-11-07 English
CONTINUING CONNECTED TRANSACTION - RENEWAL OF MASTER SALES AGREEMENT
Regulatory Filings
2018-11-01 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2018
Regulatory Filings
2018-11-01 English
NEXT DAY DISCLOSURE RETURN - CHANGES IN ISSUED SHARE CAPITAL
Regulatory Filings
2018-10-26 English
NEXT DAY DISCLOSURE RETURN
Regulatory Filings
2018-10-15 English
NEXT DAY DISCLOSURE RETURN
Regulatory Filings
2018-10-11 English
NEXT DAY DISCLOSURE RETURN
Regulatory Filings
2018-10-09 English
NEXT DAY DISCLOSURE RETURN
Regulatory Filings
2018-10-08 English
VOLUNTARY ANNOUNCEMENT - PRODUCT LICENSE AND COMMERCIALIZATION AGREEMENT
Regulatory Filings
2018-10-08 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2018
Regulatory Filings
2018-10-03 English
VOLUNTARY ANNOUNCEMENT - PRODUCT LICENSE AND COLLABORATION AGREEMENT
Regulatory Filings
2018-09-26 English
INTERIM REPORT 2018
Regulatory Filings
2018-09-11 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2018
Regulatory Filings
2018-09-04 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Regulatory Filings
2018-08-30 English
RESIGNATION OF DIRECTOR
Regulatory Filings
2018-08-30 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Regulatory Filings
2018-08-20 English
APPOINTMENT OF EXECUTIVE DIRECTOR AND NON-COMPLIANCE WITH RULE 3.10A OF THE LISTING RULES
Regulatory Filings
2018-08-20 English
ADOPTION OF RESTRICTED SHARE AWARD SCHEME
Regulatory Filings
2018-08-20 English
2018 INTERIM RESULTS ANNOUNCEMENT
Regulatory Filings
2018-08-20 English
DATE OF BOARD MEETING
Regulatory Filings
2018-08-08 English
CONNECTED TRANSACTION - ACQUISITION OF 29.9% EQUITY INTEREST IN CSPC YUANDA (DALIAN) PHARMACEUTICAL CO., LTD.
Regulatory Filings
2018-08-06 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 July 2018
Regulatory Filings
2018-08-03 English
VOLUNTARY ANNOUNCEMENT - "STATE KEY LABORATORY FOR NOVEL PHARMACEUTICAL PREPARATIONS AND EXCIPIENTS" RATED AS EXCELLENT CLASS OF STATE KEY LABORATORY
Regulatory Filings
2018-07-23 English
VOLUNTARY ANNOUNCEMENT - PRODUCT CO-DEVELOPMENT AND STRATEGIC COLLABORATION AGREEMENT
Regulatory Filings
2018-07-10 English
VOLUNTARY ANNOUNCEMENT - THE GROUP'S INVESTIGATIONAL NEW DRUG "CSPCHA115" WAS GRANTED CLINICAL TRIAL APPROVAL BY THE U.S. FDA
Regulatory Filings
2018-07-10 English
VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR THE GROUP'S "CAPTOPRIL TABLETS"
Regulatory Filings
2018-07-10 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Regulatory Filings
2018-07-09 English
APPOINTMENT OF EXECUTIVE DIRECTOR
Regulatory Filings
2018-07-09 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2018
Regulatory Filings
2018-07-03 English
VOLUNTARY ANNOUNCEMENT - ADMISSION OF THE GROUP'S "PACLITAXEL FOR INJECTION (ALBUMIN-BOUND)" TO THE "LIST OF MARKETED DRUGS OF CHINA"
Regulatory Filings
2018-06-04 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 May 2018
Regulatory Filings
2018-06-04 English
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 25 MAY 2018
Regulatory Filings
2018-05-25 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Regulatory Filings
2018-05-25 English
APPOINTMENT OF VICE-CHAIRMAN AND CHANGE OF ROTATING CHIEF EXECUTIVE OFFICER
Regulatory Filings
2018-05-25 English
UNAUDITED RESULTS FOR THE THREE MONTHS ENDED 31 MARCH 2018
Regulatory Filings
2018-05-25 English
VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR "QIMAITE" (TRAMADOL HYDROCHLORIDE TABLETS)
Regulatory Filings
2018-05-21 English
CORPORATE SOCIAL RESPONSIBILITY REPORT 2017
Regulatory Filings
2018-05-14 English
DATE OF BOARD MEETING
Regulatory Filings
2018-05-14 English
VOLUNTARY ANNOUNCEMENT - "Q101-PEGYLATED RECOMBINANT HUMAN INTERFERON-alpha2a FOR INJECTION" FOR THE TREATMENT OF HEPATITIS WAS GRANTED CLINICAL TRIAL APPROVAL
Regulatory Filings
2018-05-10 English
VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF "DOXOFYLLINE GLUCOSE FOR INJECTION" AND "DOXOFYLLINE SODIUM CHLORIDE FOR INJECTION"
Regulatory Filings
2018-05-10 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2018
Regulatory Filings
2018-05-03 English
PROXY FORM FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, 25 MAY 2018 AT 10:00 A.M. (AND AT ANY ADJOURNMENT THEREOF)
Regulatory Filings
2018-04-20 English
NOTICE OF ANNUAL GENERAL MEETING
Regulatory Filings
2018-04-20 English
PROPOSALS FOR GENERAL MANDATES TO BUY-BACK SHARES AND TO ISSUE SHARES AND MANDATE TO GRANT OPTIONS, RE-ELECTION OF THE RETIRING DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING
Regulatory Filings
2018-04-20 English
ANNUAL REPORT 2017
Regulatory Filings
2018-04-20 English
VOLUNTARY ANNOUNCEMENT - PRODUCT LICENSING AGREEMENT
Regulatory Filings
2018-04-18 English
VOLUNTARY ANNOUNCEMENT - "VINORELBINE TARTRATE LIPOSOME INJECTION" FOR THE TREATMENT OF LUNG CANCER WAS GRANTED CLINICAL TRIAL APPROVAL
Regulatory Filings
2018-04-16 English
VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR"WEIHONG"(AZITHROMYCIN TABLETS)
Regulatory Filings
2018-04-12 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2018
Regulatory Filings
2018-04-04 English
ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2017
Regulatory Filings
2018-03-19 English
VOLUNTARY ANNOUNCEMENT - "RECOMBINANT ANTI-EpCAM AND ANTI-CD3 HUMAN-MOUSE CHIMERIC BISPECIFIC ANTIBODY FOR INJECTION" WAS GRANTED DRUG CLINICAL TRIAL APPROVAL
Regulatory Filings
2018-03-16 English
VOLUNTARY ANNOUNCEMENT - THE GROUP'S DRUG "BUTYLPHTHALIDE" WAS GRANTED ORPHAN-DRUG DESIGNATION BY THE U.S. FDA
Regulatory Filings
2018-03-11 English
DATE OF BOARD MEETING
Regulatory Filings
2018-03-07 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 2018
Regulatory Filings
2018-03-02 English
VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF THE GROUP'S "PACLITAXEL FOR INJECTION (ALBUMIN-BOUND)"
Regulatory Filings
2018-02-11 English
VOLUNTARY ANNOUNCEMENT-THE GROUP'S GASTRIC CANCER DRUG "DP303c" WAS GRANTED ORPHAN-DRUG DESIGNATION BY THE U.S. FDA
Regulatory Filings
2018-02-06 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2018
Regulatory Filings
2018-02-02 English
VOLUNTARY ANNOUNCEMENT - ACQUISITION OF 39.56% EQUITY INTEREST IN WUHAN YZY BIOPHARMA CO., LTD.
Regulatory Filings
2018-01-09 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2017
Regulatory Filings
2018-01-03 English